These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 10873025

  • 1. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP, Cruz E, Xue H.
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [Abstract] [Full Text] [Related]

  • 2. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS.
    J Immunol; 1990 Dec 15; 145(12):4185-91. PubMed ID: 2124237
    [Abstract] [Full Text] [Related]

  • 3. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G, Heumann D, Gérain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser MP, Baumgartner JD.
    J Immunol; 1992 Mar 15; 148(6):1890-7. PubMed ID: 1541827
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R, Melbostad H, Loomis W, Tobar M, Hoyt DB.
    J Trauma; 2005 Sep 15; 59(3):575-82. PubMed ID: 16361898
    [Abstract] [Full Text] [Related]

  • 6. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
    Jansen PM, de Jong IW, Hart M, Kim KJ, Aarden LA, Hinshaw LB, Taylor FB, Hack CE.
    J Immunol; 1996 Jun 01; 156(11):4401-7. PubMed ID: 8666813
    [Abstract] [Full Text] [Related]

  • 7. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J, Dofferhoff AS, Mouton JW, van der Meer JW.
    J Antimicrob Chemother; 2007 May 01; 59(5):926-33. PubMed ID: 17395686
    [Abstract] [Full Text] [Related]

  • 8. Production of tumor necrosis factor-alpha and interleukin-6 in mice infected with group B streptococci.
    Teti G, Mancuso G, Tomasello F, Chiofalo MS.
    Circ Shock; 1992 Oct 01; 38(2):138-44. PubMed ID: 1423922
    [Abstract] [Full Text] [Related]

  • 9. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.
    Hildebrand F, Pape HC, Hoevel P, Krettek C, van Griensven M.
    Shock; 2003 Oct 01; 20(4):338-46. PubMed ID: 14501948
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibody to tumor necrosis factor-alpha attenuates plasma interleukin-6 levels in porcine gram-negative sepsis.
    Mullen PG, Fisher BJ, Walsh CJ, Susskind BM, Leeper-Woodford SK, Jesmok GJ, Fowler AA, Sugerman HJ.
    J Surg Res; 1994 Nov 01; 57(5):625-31. PubMed ID: 7967599
    [Abstract] [Full Text] [Related]

  • 11. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
    Hinshaw LB, Tekamp-Olson P, Chang AC, Lee PA, Taylor FB, Murray CK, Peer GT, Emerson TE, Passey RB, Kuo GC.
    Circ Shock; 1990 Mar 01; 30(3):279-92. PubMed ID: 2178801
    [Abstract] [Full Text] [Related]

  • 12. Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor.
    DeMaria EJ, Pellicane JV, Lee RB.
    J Trauma; 1993 Nov 01; 35(5):720-4; discussion 724-5. PubMed ID: 8230336
    [Abstract] [Full Text] [Related]

  • 13. Lymphocyte-derived cytokines augment macrophage tumor necrosis factor-alpha and interleukin-6 secretion during experimental gram-negative bacterial sepsis.
    Battafarano RJ, Kim SK, Dahlberg PS, Farber MS, Ratz CA, Johnston JW, Dunn DL.
    J Surg Res; 1995 Jun 01; 58(6):739-45. PubMed ID: 7791354
    [Abstract] [Full Text] [Related]

  • 14. Repeated administration of a F(ab')2 fragment of an anti-tumor necrosis factor alpha monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels.
    Boekstegers P, Weidenhöfer S, Zell R, Pilz G, Holler E, Ertel W, Kapsner T, Redl H, Schlag G, Kaul M.
    Shock; 1994 Apr 01; 1(4):237-45. PubMed ID: 7735957
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge.
    Ono S, Ueno C, Seki S, Matsumoto A, Mochizuki H.
    Surgery; 2003 Jul 01; 134(1):92-100. PubMed ID: 12874588
    [Abstract] [Full Text] [Related]

  • 16. Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model.
    Redl HR, Martin U, Khadem A, Pelinka LE, van Griensven M.
    Crit Care; 2005 Jul 01; 9(6):R735-44. PubMed ID: 16356222
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.
    Jesmok G, Lindsey C, Duerr M, Fournel M, Emerson T.
    Am J Pathol; 1992 Nov 01; 141(5):1197-207. PubMed ID: 1443053
    [Abstract] [Full Text] [Related]

  • 18. [The curative effects of anti-TNF monoclonal antibody in E. coli infected mice].
    Guo X, Wang A, Chen S, Qiu Z.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug 01; 19(4):312-4. PubMed ID: 10453575
    [Abstract] [Full Text] [Related]

  • 19. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis.
    Sharma R, Tepas JJ, Hudak ML, Mollitt DL, Wludyka PS, Teng RJ, Premachandra BR.
    J Pediatr Surg; 2007 Mar 01; 42(3):454-61. PubMed ID: 17336180
    [Abstract] [Full Text] [Related]

  • 20. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B, Zhang R, Li J, Zhang L, Ding G, Luo P, He S, Dong Y, Jiang W, Lu Y, Cao H, Zheng J, Zhou H.
    Int Immunopharmacol; 2008 Mar 01; 8(3):379-89. PubMed ID: 18279792
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.